NONOF - Novo Nordisk GAAP EPADR of DKK 5.68 revenue of DKK 65.35B; updates FY24 outlook
2024-05-02 01:40:07 ET
More on Novo Nordisk:
- Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy
- Novo Nordisk Remains The Better Buy After A Moderate Pullback
- Novo Nordisk: The Moat Won't Last Forever
- Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
- What do weight-loss drugs mean for the diet industry?